• Japanese
  • Korean
  • Chinese
Cover Image

Drug Self-Administration Markets to 2020: Drug Products, Indications, Markets and Forecasts

While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism of the digestive tract, the recent escalation in new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Now a number of factors are converging to create both risk and opportunity for drug makers and their delivery device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward self-administration for chronic diseases, shifting patient demographics in industrial countries, caregiver safety legislation, and continued pressure to control healthcare costs. These factors are giving rise to a new generation of sophisticated, application-specific injection, inhalation and transdermal drug products designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the formulation limitations of new classes of therapeutic drugs. Because of their ability to safely and reliably satisfy treatment protocols and compliance goals, non-oral drug delivery products will have a significant impact on the future of drug self-administration.

Highlights

  • Provides detailed analysis of drug self-administration market segments, market dynamics and market demographics
  • Analyzes therapeutic demand drivers and evaluates commercial drug products in more than two dozen major self-administration therapeutic segments
  • Analyzes design factors, material selection issues, technologies and market development issues for injection devices, inhalation devices and transdermal drug products designed for self-administration
  • Charts product data, market share, and forecasts to 2020
  • Profiles self-administration drug product and device participants, their product development activities, business strategies, and corporate alliances and affiliations

Table of Contents

  • Executive Summary
  • Drug Market Dynamics
  • Evolving Drug Development and Market Factors
  • Managed Care and Prescribing Trends
  • Drug Self-Administration Demand Factors
  • Shifting Patient Demographics
  • Chronic Disease and Self-administration
  • Biological Drugs Proliferating
  • Delivery Device Technology & Evolving
  • Drug Self-Administration Product Segments and Market Drivers
  • Injectable Drug Self-Administration
  • Market Sector Dynamics
  • The Shift to Prefilled Devices
  • Device Selection Factors
  • Market Segmentation & Cost
  • Product Features & Ease of Use
  • Custom Device Designs & Branding
  • Prefilled Syringes (PFS)
  • Glass PFS
  • Plastic PFS
  • Prospects for Autoinjectors
  • Key PFS Therapeutic Segments
  • The PFS Supply Chain
  • PFS Supplier Profiles
  • Pen Injectors
  • Reusable Pens
  • Disposable Pens
  • Key Pen Injector Therapeutic Segments
  • The Top Ten Pen Injector Drug Products
  • Five Segments Driving Pen Injector Growth
  • Pen Injector Company Profiles
  • Needle-free Injectors (NFI)
  • Reusable NFI
  • Disposable
  • Competitive NFI Therapeutic Segments
  • Needle-free Company Profiles
  • Inhaled Drug Self-Administration Products
  • Market Sector Dynamics
  • The Upper Respiratory Market
  • Established Therapeutic Targets
  • Dual Drug Inhalers
  • The Systemic/Deep Lung Market
  • Established Markets
  • Emerging Therapies
  • Inhaler Technology and Market Prospects
  • Inhaler Product Segments
  • Dry Powder Inhalers
  • Device Design Factors
  • Powder Technology
  • Packaging Issues
  • DPI Device Company Profiles
  • Metered Dose Inhalers
  • Manual Devices
  • Breathe Actuated Designs
  • MDI Device Company Profiles
  • Nebulizers
  • Established Nebulizer Therapies
  • Evolving Nebulizer Technology
  • Nebulizer Device Company Profiles
  • Performance Factors
  • Bioavailability
  • Dose Reproducibility
  • Active Compound Stability
  • Transdermal Drug Self-Administration
  • Market Sector Dynamics
  • Traditional Patch Markets
  • Emerging Markets
  • Transdermal Patch Market Drivers
  • Prescription Patch Design & Technology
  • Passive Patch Architecture
  • Passive Transdermal Patch Design
  • Passive Patch Construction
  • Active Transport Patch Technologies
  • Iontophoresis
  • Electroporation
  • Microporation
  • Mechanical Arrays
  • Radio Frequency
  • Thermal/Heat
  • Ultrasound
  • Prescription Patch Development Factors
  • Key Transdermal Therapeutic Markets
  • Transdermal Product Company Profiles
  • Drug Self-Administration - Therapeutic Sector Analysis & Forecasts
  • ADHD
  • Anticoagulants
  • Arthritis
  • Asthma/COPD
  • Cardiovascular
  • Contraception
  • Cystic Fibrosis
  • Diabetes
  • Hematopoietics
  • Hepatitis
  • Hormone Therapy/Replacement
  • Multiple Sclerosis
  • Neurology
  • Osteoporosis
  • Pain Management
  • Psoriasis
  • Sexual Health
  • Company Profiles
Show More
Pricing
Get Notified
Email me when related reports are published